Retinoids regulate a broad range of biological processes through two subfamilies of nuclear retinoid receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). Recently, we reported a novel type of retinoic acid antagonist (SR11335) and showed that this compound can inhibit retinoic acid (RA)-induced activation of a human immunodeficiency virus type 1 (HIV-1) promoter construct that contains a special RA response element (RARE). We have now further characterized the antagonism mediated by SR11335 and of newly synthesized structurally related compounds. Two compounds, SR11330 and SR11334, which are poor transactivators, also showed antagonist activities, inhibiting all-trans-RA (tRA) and 9-cis-RA. The retinoids inhibited transcriptional activation of RAR/RXR heterodimers effectively,while inhibition of RXR homodimers was less efficient. Inhibition was observed on several RAREs, including the TREpal, RARE, apoAI-RARE,and CRBPI-RARE. In addition, the antagonists inhibited tRA-induced differentiation of HL-60 cells. The antagonist did not interfere with DNA binding of the receptors. In limited proteolytic digestion assays, SR11335 induced resistance of the receptors to proteolysis, but the pattern of the degradation was not altered from that induced by tRA, suggesting that these antagonists induce their biological effects by competing with agonists for binding to RARs, thereby preventing the induction of conformational changes of the receptors necessary for transcriptional activation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Nevado, S. P Tenbaum, A. I. Castillo, A. Sanchez-Pacheco, and A. Aranda Activation of the human immunodeficiency virus type I long terminal repeat by 1{alpha},25-dihydroxyvitamin D3 J. Mol. Endocrinol., June 1, 2007; 38(6): 587 - 601. [Abstract] [Full Text] [PDF]

				T. M. Hanley, H. L. B. Kiefer, A. C. Schnitzler, J. E. Marcello, and G. A. Viglianti Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages J. Virol., March 15, 2004; 78(6): 2819 - 2830. [Abstract] [Full Text] [PDF]

				D. R. Soprano and K. J. Soprano Pharmacological Doses of Some Synthetic Retinoids Can Modulate Both the Aryl Hydrocarbon Receptor and Retinoid Receptor Pathways J. Nutr., January 1, 2003; 133(1): 277S - 281. [Abstract] [Full Text] [PDF]

				K. Ozono, M. Saito, D. Miura, T. Michigami, S. Nakajima, and S. Ishizuka Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1alpha ,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor Function J. Biol. Chem., November 5, 1999; 274(45): 32376 - 32381. [Abstract] [Full Text] [PDF]

				N. Ferrari, M. Pfahl, and G. Levi Retinoic Acid Receptor gamma 1 (RARgamma 1) Levels Control RARbeta 2 Expression in SK-N-BE2(c) Neuroblastoma Cells and Regulate a Differentiation-Apoptosis Switch Mol. Cell. Biol., November 1, 1998; 18(11): 6482 - 6492. [Abstract] [Full Text]

				A. Angulo, R. A. S. Chandraratna, J. F. LeBlanc, and P. Ghazal Ligand Induction of Retinoic Acid Receptors Alters an Acute Infection by Murine Cytomegalovirus J. Virol., June 1, 1998; 72(6): 4589 - 4600. [Abstract] [Full Text] [PDF]

				A. Scafonas, C. L. Wolfgang, J. L. Gabriel, K. J. Soprano, and D. R. Soprano Differential Role of Homologous Positively Charged Amino Acid Residues for Ligand Binding in Retinoic Acid Receptor alpha Compared with Retinoic Acid Receptor beta J. Biol. Chem., April 25, 1997; 272(17): 11244 - 11249. [Abstract] [Full Text] [PDF]

				E. S. Klein, J. W. Wang, B. Khalifa, S. A. Gavigan, and R. A. S. Chandraratna Recruitment of Nuclear Receptor Corepressor and Coactivator to the Retinoic Acid Receptor by Retinoid Ligands. INFLUENCE OF DNA-HETERODIMER INTERACTIONS J. Biol. Chem., June 16, 2000; 275(25): 19401 - 19408. [Abstract] [Full Text] [PDF]